Related references
Note: Only part of the references are listed.Lack of Increased Risk of Lymphoma with Thiopurine Therapy Regardless of Dose and Duration of Treatment in Japanese Patients with Inflammatory Bowel Diseases
Taku Kobayashi et al.
DIGESTION (2022)
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2019
Mee Joo Kang et al.
CANCER RESEARCH AND TREATMENT (2022)
Psoriasis Prevalence in Adults in the United States
April W. Armstrong et al.
JAMA DERMATOLOGY (2021)
Validity of Diagnostic Codes for Identification of Psoriasis Patients in Korea
Seung Pil Ham et al.
ANNALS OF DERMATOLOGY (2020)
Association of Psoriasis With the Risk of Developing or Dying of Cancer A Systematic Review and Meta-analysis
Alex M. Trafford et al.
JAMA DERMATOLOGY (2019)
Cancer risk in 892 089 patients with psoriasis in Korea: A nationwide population-based cohort study
Ji Hyun Lee et al.
JOURNAL OF DERMATOLOGY (2019)
Risk of uncommon cancers in patients with psoriasis: a Danish nationwide cohort study
P. Jensen et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Interleukin (IL)-12 and IL-23 and Their Conflicting Roles in Cancer
Juming Yan et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
Coexistence of Kaposi's sarcoma and psoriasis: is there a hidden relationship?
Lucia Brambilla et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2018)
Cancer Risk in the Early Stages of Inflammatory Bowel Disease in Korean Patients: A Nationwide Population-based Study
Yoon Suk Jung et al.
JOURNAL OF CROHNS & COLITIS (2017)
Skin cancer in patients with psoriasis
A. Egeberg et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)
The Risk of Cancer in Patients With Psoriasis A Population-Based Cohort Study in the Health Improvement Network
Zelma C. Chiesa Fuxench et al.
JAMA DERMATOLOGY (2016)
Effect of Medications on Risk of Cancer in Patients With Inflammatory Bowel Diseases: A Population-Based Cohort Study from Olmsted County, Minnesota
Siddhant Yadav et al.
MAYO CLINIC PROCEEDINGS (2015)
Obesity and Risk for Brain/CNS Tumors, Gliomas and Meningiomas: A Meta-Analysis
Theodoros N. Sergentanis et al.
PLOS ONE (2015)
Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease
Gerd R. Burmester et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Tumor necrosis factor a inhibitor therapy and cancer risk in chronic immune-mediated diseases
Kevin Haynes et al.
ARTHRITIS AND RHEUMATISM (2013)
Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up
K. A. Papp et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Risk of cancer in psoriasis: a systematic review and meta-analysis of epidemiological studies
C. Pouplard et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
A balance of interleukin-12 and-23 in cancer
Shin Foong Ngiow et al.
TRENDS IN IMMUNOLOGY (2013)
Risk of Melanoma and Nonmelanoma Skin Cancer Among Patients With Inflammatory Bowel Disease
Millie D. Long et al.
GASTROENTEROLOGY (2012)
Kaposi sarcoma and Merkel cell carcinoma after autoimmune disease
Kari Hemminki et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Risk of Malignancies in Patients With Rheumatoid Arthritis Treated With Biologic Therapy A Meta-analysis
Maria A. Lopez-Olivo et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Integrated safety analysis: Short- and long-term safety profiles of etanercept in patients with psoriasis
David M. Pariser et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
The Long-Term Safety of Adalimumab Treatment in Moderate to Severe Psoriasis A Comprehensive Analysis of All Adalimumab Exposure in All Clinical Trials
Craig Leonardi et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2011)
Tumor Necrosis Factor Therapy and the Risk of Serious Infection and Malignancy in Patients With Early Rheumatoid Arthritis A Meta-Analysis of Randomized Controlled Trials
Andrew E. Thompson et al.
ARTHRITIS AND RHEUMATISM (2011)
The risk of cancer in patients with psoriasis: A population-based cohort study in Taiwan
Yi-Ju Chen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry
X. Mariette et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Increased Risk for Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel Disease
Millie D. Long et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Assessment of the long-term safety and effectiveness of etanercept for the treatment of psoriasis in an adult population
Kim A. Papp et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Cancer risk in hospitalised psoriasis patients: a follow-up study in Sweden
J. Ji et al.
BRITISH JOURNAL OF CANCER (2009)
Thirty years of national health insurance in South Korea: lessons for achieving universal health care coverage
Soonman Kwon
HEALTH POLICY AND PLANNING (2009)
Psoriasis and Risk of Incident Cancer: An Inception Cohort Study with a Nested Case-Control Analysis
Yolanda B. Brauchli et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Biologic treatment of rheumatoid arthritis and the risk of malignancy - Analyses from a large US observational study
Frederick Wolfe et al.
ARTHRITIS AND RHEUMATISM (2007)
Interferons, immunity and cancer immunoediting
Gavin P. Dunn et al.
NATURE REVIEWS IMMUNOLOGY (2006)
The risk of lymphoma in patients with psoriasis
Joel M. Gelfand et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Tumor necrosis factor α antagonist use and cancer in patients with rheumatoid arthritis
Soko Setoguchi et al.
ARTHRITIS AND RHEUMATISM (2006)
IL-23 promotes tumour incidence and growth
John L. Langowski et al.
NATURE (2006)
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies - Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
T Bongartz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Prevalence and treatment of psoriasis in the United Kingdom - A population-based study
JM Gelfand et al.
ARCHIVES OF DERMATOLOGY (2005)
Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas
P Geborek et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality
V Sundararajan et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2004)
Lymphoma in rheumatoid arthritis - The effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients
F Wolfe et al.
ARTHRITIS AND RHEUMATISM (2004)
Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study
CF Paul et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Crucial role of TNF-α in CD8 T cell-mediated elimination of 3LL-A9 Lewis lung carcinoma cells in vivo
A Prévost-Blondel et al.
JOURNAL OF IMMUNOLOGY (2000)
Psoriasis, its treatment, and cancer in a cohort of finnish patients
A Hannuksela-Svahn et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2000)
Share Paper
